Orthofix Medical (OFIX) Shareholder's Equity Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Orthofix Medical | 375.38 Mn | 254.51 Mn | 139.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.17% |
| Dec 31, 2025 | 4.75% |
| Sep 30, 2025 | 4.51% |
| Jun 30, 2025 | 5.84% |
| Mar 31, 2025 | 5.22% |
| Dec 31, 2024 | 8.96% |
| Sep 30, 2024 | 11.41% |
| Jun 30, 2024 | 9.44% |
| Mar 31, 2024 | 10.66% |
| Dec 31, 2023 | 12.29% |
| Sep 30, 2023 | 13.74% |
| Jun 30, 2023 | 14.88% |
| Mar 31, 2023 | 16.22% |
| Dec 31, 2022 | 2.58% |
| Sep 30, 2022 | 3.17% |
| Jun 30, 2022 | 4.31% |
| Mar 31, 2022 | 4.67% |
| Dec 31, 2021 | 5.04% |
| Sep 30, 2021 | 5.96% |
| Jun 30, 2021 | 7.01% |
| Mar 31, 2021 | 5.19% |
| Dec 31, 2020 | 4.21% |
| Sep 30, 2020 | 3.61% |
| Jun 30, 2020 | 3.00% |
| Mar 31, 2020 | 4.11% |
| Dec 31, 2019 | 1.80% |
| Sep 30, 2019 | 0.09% |
| Jun 30, 2019 | 2.65% |
| Mar 31, 2019 | 2.72% |
| Dec 31, 2018 | 2.54% |
| Sep 30, 2018 | 1.04% |
| Jun 30, 2018 | -0.75% |
| Mar 31, 2018 | -2.80% |
| Dec 31, 2017 | -3.61% |
| Sep 30, 2017 | -3.01% |
| Jun 30, 2017 | -2.41% |
| Mar 31, 2017 | -2.20% |
| Dec 31, 2016 | -1.30% |
| Sep 30, 2016 | -1.33% |
| Jun 30, 2016 | -1.60% |
| Mar 31, 2016 | 0.86% |
| Dec 31, 2015 | -0.25% |
| Dec 31, 2014 | 110.85% |